Cargando…

Performance of liver stiffness measurements obtained with FibroScan is affected by glucose metabolism in patients with nonalcoholic fatty liver disease

BACKGROUND: The performance of liver stiffness measurements (LSMs) obtained using FibroScan can be affected by several factors, and cut-off values are different for fibrosis caused by various aetiologies. The study aims to evaluate the diagnostic accuracy of LSM in nonalcoholic fatty liver disease (...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Xinyu, Chang, Xinxia, Wu, Shengdi, Sun, Xiaoyang, Zhu, Xiaopeng, Wang, Liu, Xu, Yushan, Yao, Xiuzhong, Rao, Shengxiang, Hu, Xiqi, Xia, Mingfeng, Bian, Hua, Yan, Hongmei, Gao, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7986416/
https://www.ncbi.nlm.nih.gov/pubmed/33757528
http://dx.doi.org/10.1186/s12944-021-01453-5
_version_ 1783668440547983360
author Yang, Xinyu
Chang, Xinxia
Wu, Shengdi
Sun, Xiaoyang
Zhu, Xiaopeng
Wang, Liu
Xu, Yushan
Yao, Xiuzhong
Rao, Shengxiang
Hu, Xiqi
Xia, Mingfeng
Bian, Hua
Yan, Hongmei
Gao, Xin
author_facet Yang, Xinyu
Chang, Xinxia
Wu, Shengdi
Sun, Xiaoyang
Zhu, Xiaopeng
Wang, Liu
Xu, Yushan
Yao, Xiuzhong
Rao, Shengxiang
Hu, Xiqi
Xia, Mingfeng
Bian, Hua
Yan, Hongmei
Gao, Xin
author_sort Yang, Xinyu
collection PubMed
description BACKGROUND: The performance of liver stiffness measurements (LSMs) obtained using FibroScan can be affected by several factors, and cut-off values are different for fibrosis caused by various aetiologies. The study aims to evaluate the diagnostic accuracy of LSM in nonalcoholic fatty liver disease (NAFLD) patients with abnormal glucose metabolism and investigate whether the LSM value would be affected by metabolic indicators. METHODS: The study involved 91 NAFLD patients with abnormal glucose metabolism who underwent liver biopsy. The diagnostic accuracy of LSM value was evaluated by the receiver operator characteristic (ROC) curves, with the biopsy results taken as the gold standard. Multivariate linear regression and subgroup analysis were performed to determine the correlated indicators. RESULTS: The areas under the ROC curves (AUROCs) of LSM values for detecting fibrosis stage ≥1, 2, 3 and 4 were 0.793 (95% confidence interval [CI]: 0.695–0.871), 0.764 (95% CI: 0.663–0.846), 0.837 (95% CI: 0.744–0.906) and 0.902 (95% CI: 0.822–0.955), with cut-off values of 6.3, 7.6, 8.3 and 13.8 kPa, respectively. Multivariate linear regression demonstrated that haemoglobin A1c (HbA1c, β = 0.205, P = 0.026) and alanine aminotransferase (ALT, β = 0.192, P = 0.047) were independently associated with the LSM value after adjustment for fibrosis stage, ballooning and inflammation grade from liver biopsy. Subgroup analysis demonstrated that LSM values were slightly higher in patients with HbA1c ≥7% than in those with HbA1c < 7% and in patients with body mass index (BMI) ≥30 kg/m(2) than in those with BMI < 30 kg/m(2). CONCLUSIONS: FibroScan was valuable for the evaluation of liver fibrosis in NAFLD patients with abnormal glucose metabolism. FibroScan is recommended to evaluate severe fibrosis, especially to exclude advanced fibrosis. Glucose metabolism state may affect LSM values. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12944-021-01453-5.
format Online
Article
Text
id pubmed-7986416
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-79864162021-03-24 Performance of liver stiffness measurements obtained with FibroScan is affected by glucose metabolism in patients with nonalcoholic fatty liver disease Yang, Xinyu Chang, Xinxia Wu, Shengdi Sun, Xiaoyang Zhu, Xiaopeng Wang, Liu Xu, Yushan Yao, Xiuzhong Rao, Shengxiang Hu, Xiqi Xia, Mingfeng Bian, Hua Yan, Hongmei Gao, Xin Lipids Health Dis Research BACKGROUND: The performance of liver stiffness measurements (LSMs) obtained using FibroScan can be affected by several factors, and cut-off values are different for fibrosis caused by various aetiologies. The study aims to evaluate the diagnostic accuracy of LSM in nonalcoholic fatty liver disease (NAFLD) patients with abnormal glucose metabolism and investigate whether the LSM value would be affected by metabolic indicators. METHODS: The study involved 91 NAFLD patients with abnormal glucose metabolism who underwent liver biopsy. The diagnostic accuracy of LSM value was evaluated by the receiver operator characteristic (ROC) curves, with the biopsy results taken as the gold standard. Multivariate linear regression and subgroup analysis were performed to determine the correlated indicators. RESULTS: The areas under the ROC curves (AUROCs) of LSM values for detecting fibrosis stage ≥1, 2, 3 and 4 were 0.793 (95% confidence interval [CI]: 0.695–0.871), 0.764 (95% CI: 0.663–0.846), 0.837 (95% CI: 0.744–0.906) and 0.902 (95% CI: 0.822–0.955), with cut-off values of 6.3, 7.6, 8.3 and 13.8 kPa, respectively. Multivariate linear regression demonstrated that haemoglobin A1c (HbA1c, β = 0.205, P = 0.026) and alanine aminotransferase (ALT, β = 0.192, P = 0.047) were independently associated with the LSM value after adjustment for fibrosis stage, ballooning and inflammation grade from liver biopsy. Subgroup analysis demonstrated that LSM values were slightly higher in patients with HbA1c ≥7% than in those with HbA1c < 7% and in patients with body mass index (BMI) ≥30 kg/m(2) than in those with BMI < 30 kg/m(2). CONCLUSIONS: FibroScan was valuable for the evaluation of liver fibrosis in NAFLD patients with abnormal glucose metabolism. FibroScan is recommended to evaluate severe fibrosis, especially to exclude advanced fibrosis. Glucose metabolism state may affect LSM values. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12944-021-01453-5. BioMed Central 2021-03-23 /pmc/articles/PMC7986416/ /pubmed/33757528 http://dx.doi.org/10.1186/s12944-021-01453-5 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Yang, Xinyu
Chang, Xinxia
Wu, Shengdi
Sun, Xiaoyang
Zhu, Xiaopeng
Wang, Liu
Xu, Yushan
Yao, Xiuzhong
Rao, Shengxiang
Hu, Xiqi
Xia, Mingfeng
Bian, Hua
Yan, Hongmei
Gao, Xin
Performance of liver stiffness measurements obtained with FibroScan is affected by glucose metabolism in patients with nonalcoholic fatty liver disease
title Performance of liver stiffness measurements obtained with FibroScan is affected by glucose metabolism in patients with nonalcoholic fatty liver disease
title_full Performance of liver stiffness measurements obtained with FibroScan is affected by glucose metabolism in patients with nonalcoholic fatty liver disease
title_fullStr Performance of liver stiffness measurements obtained with FibroScan is affected by glucose metabolism in patients with nonalcoholic fatty liver disease
title_full_unstemmed Performance of liver stiffness measurements obtained with FibroScan is affected by glucose metabolism in patients with nonalcoholic fatty liver disease
title_short Performance of liver stiffness measurements obtained with FibroScan is affected by glucose metabolism in patients with nonalcoholic fatty liver disease
title_sort performance of liver stiffness measurements obtained with fibroscan is affected by glucose metabolism in patients with nonalcoholic fatty liver disease
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7986416/
https://www.ncbi.nlm.nih.gov/pubmed/33757528
http://dx.doi.org/10.1186/s12944-021-01453-5
work_keys_str_mv AT yangxinyu performanceofliverstiffnessmeasurementsobtainedwithfibroscanisaffectedbyglucosemetabolisminpatientswithnonalcoholicfattyliverdisease
AT changxinxia performanceofliverstiffnessmeasurementsobtainedwithfibroscanisaffectedbyglucosemetabolisminpatientswithnonalcoholicfattyliverdisease
AT wushengdi performanceofliverstiffnessmeasurementsobtainedwithfibroscanisaffectedbyglucosemetabolisminpatientswithnonalcoholicfattyliverdisease
AT sunxiaoyang performanceofliverstiffnessmeasurementsobtainedwithfibroscanisaffectedbyglucosemetabolisminpatientswithnonalcoholicfattyliverdisease
AT zhuxiaopeng performanceofliverstiffnessmeasurementsobtainedwithfibroscanisaffectedbyglucosemetabolisminpatientswithnonalcoholicfattyliverdisease
AT wangliu performanceofliverstiffnessmeasurementsobtainedwithfibroscanisaffectedbyglucosemetabolisminpatientswithnonalcoholicfattyliverdisease
AT xuyushan performanceofliverstiffnessmeasurementsobtainedwithfibroscanisaffectedbyglucosemetabolisminpatientswithnonalcoholicfattyliverdisease
AT yaoxiuzhong performanceofliverstiffnessmeasurementsobtainedwithfibroscanisaffectedbyglucosemetabolisminpatientswithnonalcoholicfattyliverdisease
AT raoshengxiang performanceofliverstiffnessmeasurementsobtainedwithfibroscanisaffectedbyglucosemetabolisminpatientswithnonalcoholicfattyliverdisease
AT huxiqi performanceofliverstiffnessmeasurementsobtainedwithfibroscanisaffectedbyglucosemetabolisminpatientswithnonalcoholicfattyliverdisease
AT xiamingfeng performanceofliverstiffnessmeasurementsobtainedwithfibroscanisaffectedbyglucosemetabolisminpatientswithnonalcoholicfattyliverdisease
AT bianhua performanceofliverstiffnessmeasurementsobtainedwithfibroscanisaffectedbyglucosemetabolisminpatientswithnonalcoholicfattyliverdisease
AT yanhongmei performanceofliverstiffnessmeasurementsobtainedwithfibroscanisaffectedbyglucosemetabolisminpatientswithnonalcoholicfattyliverdisease
AT gaoxin performanceofliverstiffnessmeasurementsobtainedwithfibroscanisaffectedbyglucosemetabolisminpatientswithnonalcoholicfattyliverdisease